Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 269Unknown 84Terminated 80Recruiting 54Active not recruiting 24Withdrawn 20Not yet recruiting 16Suspended 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 11Cyclophosphamide 9Magnetic Resonance Spectroscopy 8pembrolizumab 6Cisplatin 6Bevacizumab 6Radiosurgery 5Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × Cetuximab × Clear all
NCT05200442 2026-05-08

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

University of Chicago

Phase 1/2 Suspended
53 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡